These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 2577394)
1. Vancomycin therapy for gram-positive peritonitis in patients on CAPD. Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394 [TBL] [Abstract][Full Text] [Related]
2. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie. Klaus G; Schaefer F; Müller-Wiefel D; Mehls O Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728 [TBL] [Abstract][Full Text] [Related]
3. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Mars RL; Moles K; Pope K; Hargrove P Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311 [TBL] [Abstract][Full Text] [Related]
4. Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis. Obermiller LE; Tzamaloukas AH; Leymon P; Avasthi PS Clin Nephrol; 1985 Nov; 24(5):256-60. PubMed ID: 3907908 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of vancomycin plus tobramycin as antiperitonitis regimen for patients on CAPD. Vargemezis V; Thodis E; Pasadakis P; Martinis G; Kousta E Adv Perit Dial; 1990; 6():123-5. PubMed ID: 1982788 [TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis--a prospective, randomized comparison of intermittent v continuous therapy. Boyce NW; Wood C; Thomson NM; Kerr P; Atkins RC Am J Kidney Dis; 1988 Oct; 12(4):304-6. PubMed ID: 3177373 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Fuiano G; Sepe V; Viscione M; Nani E; Conte G Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380 [TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis. Gray HH; Goulding S; Eykyn SJ Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227 [TBL] [Abstract][Full Text] [Related]
15. Netilmycin and vancomycin in the treatment of peritonitis in CAPD patients. Were AJ; Marsden A; Tooth A; Ramsden R; Mistry CD; Gokal R Clin Nephrol; 1992 Apr; 37(4):209-13. PubMed ID: 1582059 [TBL] [Abstract][Full Text] [Related]
16. Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel. Benjamin J; Ben-Ezer Gradus D; Mostoslavski M; Rapoport J; Chaimovitz C Isr J Med Sci; 1989 Dec; 25(12):699-702. PubMed ID: 2613500 [TBL] [Abstract][Full Text] [Related]